{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:20:02Z","timestamp":1783423202938,"version":"3.54.6"},"reference-count":39,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Terumo Europe N.V.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Percutaneous coronary intervention (PCI) has evolved significantly over the past decade with approximately 30% of patients presenting with complex coronary artery disease, posing heightened procedural and long-term risks. Complexity in PCI is increasingly recognised as multifactorial, encompassing lesion, procedural and patient-related characteristics. The Ultimaster Nagomi sirolimus-eluting coronary stent system is designed to address the challenges of complex PCI. The NAGOMI COMPLEX study aims to assess its safety and clinical performance in a comprehensively defined complex PCI population, reflecting routine clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, multicentre, single-arm cohort study enrolling 3000 subjects undergoing complex PCI across 52 European sites. Eligible patients must meet at least one complex PCI criterion, such as multivessel PCI, bifurcation lesions, chronic total occlusions or long total stent length implantation (&gt;60\u2009mm). Patients will undergo PCI using the Ultimaster Nagomi sirolimus-eluting coronary stent system, with follow-up assessments conducted at 30 days, 6 months, 1 year and 2 years. The primary endpoint is Target Lesion Failure at 1 year, defined as a composite of cardiovascular death, target-vessel myocardial infarction and clinically driven target lesion revascularisation. Secondary endpoints include device success, lesion success, procedure success, rates of stent thrombosis, bleeding complications (Bleeding Academic Research Consortium (BARC 3\u20135)), patient-reported outcomes (EQ-5D-5L, Seattle Angina Questionnaire (SAQ-7)) and resource utilisation for health-economic analysis. Subgroup analyses will explore outcomes across clinical and procedural complexity criteria. Clinical events will be adjudicated by an independent Clinical Events Committee, while a Data Monitoring Committee will oversee safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study complies with the Declaration of Helsinki, EU MDR 2017\/745, ISO 14155:2020, EU Regulation 2016\/679 (General Data Protection Regulation), GCP and applicable national regulations. Ethics Committee approval has been obtained at all participating sites. Written informed consent is required from all subjects. Results will be disseminated through peer-reviewed publications and scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05705973\">NCT05705973<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116572","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:11:15Z","timestamp":1783422675000},"page":"e116572","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, procedural and patient-reported outcomes of the Ultimaster Nagomi sirolimus-eluting coronary stent in complex percutaneous coronary intervention: the NAGOMI COMPLEX prospective cohort study protocol"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct05705973","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8890","authenticated-orcid":false,"given":"Mamas","family":"Mamas","sequence":"first","affiliation":[{"name":"Cardiovascular Research Group, Keele University, Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Stankovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Albert","family":"Byrne","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Hospital, Dublin, Ireland"},{"name":"School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Chevalier","sequence":"additional","affiliation":[{"name":"Institut Cardiovasculaire Paris Sud, Jacques Cartier Private Hospital, Massy, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Aminian","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Wallonie, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2026070704100800000_16.7.e116572.1","unstructured":"Ahmad MMP , Reddivari AKR , Mungee S . Percutaneous coronary intervention. Treasure Island (FL): StatPearls Publishing, 2025. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556123"},{"key":"2026070704100800000_16.7.e116572.2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4244\/EIJ-D-23-00013","article-title":"Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials","volume":"19","author":"Bujak","year":"2023","journal-title":"EuroIntervention"},{"key":"2026070704100800000_16.7.e116572.3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamacardio.2024.3216","article-title":"Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis","volume":"9","author":"Carvalho","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026070704100800000_16.7.e116572.4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2024.10.004","article-title":"Dual antiplatelet therapy duration and stent type in patients with high bleeding risk: A systematic review and network meta-analysis","volume":"279","author":"Saito","year":"2025","journal-title":"Am Heart J"},{"key":"2026070704100800000_16.7.e116572.5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(23)02454-6","article-title":"Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis","volume":"403","author":"Stone","year":"2024","journal-title":"Lancet"},{"key":"2026070704100800000_16.7.e116572.6","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-00361"},{"key":"2026070704100800000_16.7.e116572.7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4244\/EIJV16I7A100","article-title":"Complex PCI: time for a universal definition","volume":"16","author":"Wykrzykowska","year":"2020","journal-title":"EuroIntervention"},{"key":"2026070704100800000_16.7.e116572.8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.31083\/j.rcm2306197","article-title":"Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part I: Bifurcations, Left Main Disease, and Calcifications","volume":"23","author":"Feldman","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"2026070704100800000_16.7.e116572.9","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2306209","article-title":"Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies","volume":"23","author":"Feldman","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"2026070704100800000_16.7.e116572.10","first-page":"583","article-title":"Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study","volume":"99","author":"Kandzari","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026070704100800000_16.7.e116572.11","first-page":"212","article-title":"Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention","volume":"102","author":"Piccolo","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026070704100800000_16.7.e116572.12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029057","article-title":"Complex Percutaneous Coronary Intervention Outcomes in Older Adults","volume":"12","author":"Hanna","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026070704100800000_16.7.e116572.13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00392-022-01994-4","article-title":"Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials","volume":"111","author":"Hemetsberger","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"2026070704100800000_16.7.e116572.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741"},{"key":"2026070704100800000_16.7.e116572.15","article-title":"Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry","volume":"51","author":"Kobo","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026070704100800000_16.7.e116572.16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004972","article-title":"Sex Differences in Percutaneous Coronary Intervention-Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology","volume":"6","author":"Heer","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026070704100800000_16.7.e116572.17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102844","article-title":"Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample","volume":"13","author":"Horne","year":"2024","journal-title":"J Clin Med"},{"key":"2026070704100800000_16.7.e116572.18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00392-025-02618-3","article-title":"Clinical outcomes after complex and high-risk percutaneous coronary intervention according to baseline chronic kidney disease","volume":"114","author":"Di Muro","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"2026070704100800000_16.7.e116572.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01352-0","article-title":"Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and\/or percutaneous coronary intervention","volume":"20","author":"Roule","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2026070704100800000_16.7.e116572.20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12928-025-01151-4","article-title":"Long-term bleeding events post-percutaneous coronary intervention in patients with malignancy with and without anticoagulant therapy","volume":"40","author":"Otsuka","year":"2025","journal-title":"Cardiovasc Interv Ther"},{"key":"2026070704100800000_16.7.e116572.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114967"},{"key":"2026070704100800000_16.7.e116572.22","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-01197"},{"key":"2026070704100800000_16.7.e116572.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108749"},{"key":"2026070704100800000_16.7.e116572.24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10557-020-07094-7","article-title":"Overlapping Drug-Eluting Stent Is Associated with Increased Definite Stent Thrombosis and Revascularization: Results from 15,561 Patients in the AUTHENTIC Study","volume":"35","author":"Chen","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026070704100800000_16.7.e116572.25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/00033197211014686","article-title":"Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry","volume":"72","author":"Negreira-Caama\u00f1o","year":"2021","journal-title":"Angiology"},{"key":"2026070704100800000_16.7.e116572.26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00059-022-05152-4","article-title":"Comparison of outcomes between single long stent and overlapping stents: a meta-analysis of the literature","volume":"48","author":"\u015eayl\u0131k","year":"2023","journal-title":"Herz"},{"key":"2026070704100800000_16.7.e116572.27","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0140-6736(25)01571-5","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial","volume":"406","author":"Kang","year":"2025","journal-title":"Lancet"},{"key":"2026070704100800000_16.7.e116572.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy223"},{"key":"2026070704100800000_16.7.e116572.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"2026070704100800000_16.7.e116572.30","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0642-5"},{"key":"2026070704100800000_16.7.e116572.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.000967"},{"key":"2026070704100800000_16.7.e116572.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz372"},{"key":"2026070704100800000_16.7.e116572.33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz453"},{"key":"2026070704100800000_16.7.e116572.34","unstructured":"SAS software [program]. 9.4 version. Cary, NC, USA SAS Institute Inc; 2025."},{"key":"2026070704100800000_16.7.e116572.35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamacardio.2020.6814","article-title":"Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model","volume":"6","author":"Urban","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026070704100800000_16.7.e116572.36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2023.02.016","article-title":"Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry","volume":"261","author":"Gautier","year":"2023","journal-title":"Am Heart J"},{"key":"2026070704100800000_16.7.e116572.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.09.048"},{"key":"2026070704100800000_16.7.e116572.38","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV11SVA5"},{"key":"2026070704100800000_16.7.e116572.39","doi-asserted-by":"publisher","DOI":"10.1136\/heart.86.5.485"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:11:25Z","timestamp":1783422685000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,7]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-116572"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116572","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}